首頁 > 市場調查報告書 > 消費品

寵物產品

市場調查報告書

商品編碼

2044476

寵物眼科護理市場預測至2034年－全球產品、設備、適應症、給藥途徑、動物種類、最終用戶、通路和區域分析

Pet Eye Care Market Forecasts to 2034 - Global Analysis By Product, Equipment, Indication, Route of Administration, Animal Type, End User, Distribution Channel, and By Geography

出版日期: 2026年05月11日 | 出版商:

Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，預計到 2026 年，全球寵物眼科護理市場規模將達到 20 億美元，並在預測期內以 7.8% 的複合年成長率成長，到 2034 年將達到 38 億美元。

寵物眼科護理涵蓋一系列用於診斷、治療和管理伴侶動物（如犬、貓和馬）眼科疾病的藥品和治療產品。白內障、青光眼、結膜炎、乾眼症和角膜潰瘍等常見疾病促使獸醫更加關注寵物眼部健康，也提高了飼主的眼部意識提升。該市場包括眼藥水、口服藥物和注射劑，可在診所和家中使用。寵物數量的增加、寵物「擬人化」以及獸醫眼科學的進步，都推動了全球市場對專業眼科護理解決方案的需求不斷成長。

寵物飼養數量的增加以及寵物「人性化」的趨勢

寵物家庭數量的不斷成長，以及將寵物視為家庭成員的趨勢日益盛行，直接推動了對包括眼科在內的先進醫療服務的需求。將犬貓視為家庭成員的飼主更願意投資於專業的治療、定期檢查以及針對以往被忽視的眼科疾病的手術。這種情感紐帶導致已開發國家獸醫支出增加，寵物健康保險普及率上升。隨著人們對可治療眼科疾病的認知透過線上寵物社群和獸醫社群媒體傳播開來，飼主更加積極主動地尋求治療，從而擴大了眼科藥品和治療產品的潛在患者群體。

先進眼科治療高成本

專業的獸醫眼科手術、診斷設備和處方藥對許多寵物飼主來說仍然價格高昂，限制了市場准入。獸醫眼科護理需要轉診至專科醫生，導致諮詢費高昂，而白內障手術和角膜移植等手術費用可能高達數千美元。藥物治療，尤其是新配方藥物，由於學名藥選擇有限和監管核准標準嚴格，價格也十分昂貴。在寵物保險不普及的地區，飼主可能選擇緩解基本症狀而非根治。這種費用障礙對低收入家庭的影響尤其嚴重，導致治療中斷，儘管人們對現有治療方法的認知不斷提高，但仍阻礙了市場的潛在擴張。

新型藥物遞送系統的開發

眼科藥物輸送系統的創新為提高常見寵物眼科疾病的治療順從性和療效提供了重要機會。緩釋植入植入、淚小管栓塞和隱形眼鏡式輸送系統可以減少眼藥水的使用頻率，從而解決每天多次給不配合的寵物滴眼的難題。用於治療青光眼等疾病的長效注射劑可以減少寵物就診次數，同時維持藥物濃度穩定。這些技術進步提高了飼主的便利性和治療依從性，並有望拓展先前因每日用藥不便而選擇使用眼科藥物的寵物飼主市場。投資於專有輸送平台的公司預計將在這個尚未開發的市場中佔據可觀的佔有率。

眼部感染疾病中抗生素抗藥性增加

獸醫眼科中局部抗生素的廣泛使用，有時甚至是不恰當的使用，加劇了常見眼部病原體的抗藥性。例如，葡萄球菌和綠膿桿菌等常引起犬貓結膜炎的細菌，對第一線抗生素的敏感性正在降低，這使得治療方案更加複雜，感染病程也延長。這種抗藥性迫使人們研發更新、更昂貴的藥物和聯合治療，增加了治療成本和潛在副作用的風險。對伴侶動物抗生素使用的監管也可能限制某些產品的核准，或要求提供針對抗藥性菌株的額外療效證明。如果不採取積極主動的抗生素管理措施，這種趨勢將威脅到長期的治療效果和市場的永續性。

新冠疫情的影響：

新冠疫情對寵物眼科市場產生了複雜的影響。疫情初期，寵物就診受到限制，但最終促使寵物飼養量和醫療支出增加。封鎖措施導致寵物領養數量顯著成長，擴大了長期患者群體。 2020年初，非緊急眼科就診被推遲，但針對乾眼症等慢性疾病的遠距醫療使得持續照護成為可能。遠距辦公的普及也讓飼主更容易給寵物滴眼藥水，提高了治療順從性。隨著獸醫院在加強安全措施後重新開放，積壓的擇期手術需求推動了市場的強勁復甦。總而言之，疫情加速了人們將寵物視為重要家庭成員，並認為它們需要包括專業眼科在內的全面醫療保健的趨勢。

在預測期內，眼藥水細分市場預計將佔據最大佔有率。

在預測期內，眼藥水、眼膏和凝膠預計將佔據最大的市場佔有率。這主要是由於結膜炎、角膜乾燥症（角膜結膜乾燥症）和角膜潰瘍等易於治療的前段眼部疾病的普遍存在。眼藥水、眼膏和凝膠通常是獸醫的首選處方藥，因為它們可以直接用於患處，起效迅速，全身副作用極小。飼主傾向於選擇無需專業培訓即可在家使用的非侵入性治療方法進一步鞏固了該細分市場的領先地位。非專利藥和市售潤滑劑的普及也促進了銷售的成長，而無防腐劑配方的不斷創新則提高了所有動物物種的用藥舒適度和用藥依從性。

在預測期內，貓咪細分市場預計將呈現最高的複合年成長率。

在預測期內，貓科市場預計將呈現最高的成長率。這反映了寵物貓數量的增加以及人們對貓特有眼科疾病的認知不斷提高。諸如貓皰疹病毒相關性結膜炎、嗜酸性粒細胞角膜炎和進行性性視網膜萎縮等疾病正日益引起獸醫的專業關注。雖然都市化和貓咪室內生活時間的增加導致某些眼科疾病的盛行率上升，但影像技術的進步使得早期檢測成為可能。貓用眼藥水和口服藥物的日益普及提高了治療依從性，即使是以前難以用藥的貓也能如此。隨著越來越多的飼主意識到貓和狗一樣可以從積極的眼科護理中受益，這個市場的成長速度超過了成熟的犬類市場。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這得益於其較高的寵物擁有率、先進的獸醫基礎設施和普及的寵物健康保險。光是在美國，就有超過8,500萬戶家庭擁有寵物，眼科轉診通常包含在綜合保險計畫中。該地區主要公司和專業動物眼科診所的存在確保了產品的快速供應和專家的及時就診。獸醫協會和寵物健康宣傳活動提高了公眾對可治療眼科疾病的認知，鼓勵早期療育。消費者對先進診斷和手術的高意願將使北美在整個預測期內保持其市場主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、印度和東南亞國家寵物擁有量的快速成長，以及中產階級可支配收入的提高。都市化和出生率下降推動了伴侶動物數量的成長，而受西方影響的「寵物人性化」趨勢則推動了對專業獸醫服務的需求。新的獸醫學院和專科培訓課程正在擴大能夠提供先進眼科護理的眼科醫生和技術人員的人才儲備。政府加強動物醫療保健基礎設施建設的努力以及國內平價藥品產量的增加，進一步加速了市場成長。隨著宣傳宣傳活動深入以往服務不足的農村地區，亞太地區正成為寵物眼科護理領域成長最快的區域市場。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

企業概況
- 對其他市場參與者（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域細分
- 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第13章戰略市場資訊

工業價值網路和供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第14章產業趨勢與策略舉措

併購
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第15章：公司簡介

Zoetis Inc.
Elanco Animal Health Incorporated
Boehringer Ingelheim International GmbH
Merck & Co., Inc.
Virbac
Dechra Pharmaceuticals PLC
Vetoquinol SA
Ceva Sante Animale
Hester Biosciences Limited
Ocu-GLO
I-MED Pharma Inc.
Akorn Operating Company LLC
Menicon Co., Ltd.
Optixcare
Nutramax Laboratories Veterinary Sciences Inc.

簡介目錄圖表

Product Code: SMRC36265

According to Stratistics MRC, the Global Pet Eye Care Market is accounted for $2.0 billion in 2026 and is expected to reach $3.8 billion by 2034 growing at a CAGR of 7.8% during the forecast period. Pet eye care encompasses a range of pharmaceutical and therapeutic products designed to diagnose, treat, and manage ocular conditions in companion animals including dogs, cats, and horses. Common ailments such as cataracts, glaucoma, conjunctivitis, dry eye, and corneal ulcers are driving increased veterinary attention and owner awareness. The market includes topical solutions, oral medications, and injectable therapies administered in clinical or home settings. Rising pet ownership, humanization of pets and advancements in veterinary ophthalmology collectively contribute to the expanding demand for specialized eye care solutions across global markets.

Market Dynamics:

Driver:

Increasing pet ownership and pet humanization trends

Rising numbers of households adopting companion animals, coupled with the growing tendency to treat pets as family members, directly fuels demand for advanced medical care including ophthalmology. Owners who consider their dogs and cats as integral family members are more willing to invest in specialized treatments, routine checkups, and surgical interventions for eye conditions that would have previously been overlooked. This emotional bond translates into higher veterinary spending across developed economies, with pet health insurance penetration also rising. As awareness of treatable eye diseases spreads through online pet communities and veterinary social media, owners proactively seek care, expanding the addressable patient population for pharmaceutical and therapeutic eye products.

Restraint:

High cost of advanced ophthalmic treatments

Specialized veterinary eye surgeries, diagnostic equipment, and prescription medications remain prohibitively expensive for many pet owners, limiting market accessibility. Veterinary ophthalmology requires referral to specialists, increasing consultation fees, while procedures such as cataract surgery or corneal grafting can cost thousands of dollars. Pharmaceutical treatments, particularly newer formulations, carry premium pricing due to limited generic alternatives and stringent regulatory approvals. In regions without pet insurance penetration, owners may opt for basic symptomatic relief rather than definitive care. This cost barrier disproportionately affects lower-income households and contributes to treatment abandonment, restraining potential market expansion despite growing awareness of available treatments.

Opportunity:

Development of novel drug delivery systems

Innovations in ophthalmic drug delivery present significant opportunities to improve treatment adherence and therapeutic outcomes for common pet eye diseases. Sustained-release implants, punctal plugs, and contact lens-based delivery systems can reduce the frequency of topical applications, addressing the challenge of administering eye drops multiple times daily to uncooperative animals. Long-acting injectable formulations for conditions like glaucoma reduce veterinary visit burdens while maintaining consistent drug levels. These technological advances enhance owner convenience and treatment compliance, potentially expanding the addressable market among pet owners who previously found daily medication regimens impractical. Companies investing in proprietary delivery platforms may capture significant market share in this underserved segment.

Threat:

Increasing antimicrobial resistance in ocular infections

Widespread and sometimes inappropriate use of topical antibiotics in veterinary ophthalmology contributes to rising resistance patterns among common ocular pathogens. Bacteria such as Staphylococcus and Pseudomonas species frequently implicated in canine and feline conjunctivitis are showing reduced susceptibility to first-line antibiotics, complicating treatment protocols and prolonging infection duration. This resistance necessitates development of newer, more expensive agents or combination therapies, increasing treatment costs and potential side effects. Regulatory scrutiny over antibiotic use in companion animals may also restrict certain product approvals or require additional demonstration of efficacy against resistant strains. Without proactive antimicrobial stewardship, this trend threatens long-term treatment effectiveness and market sustainability.

Covid-19 Impact:

The COVID-19 pandemic had a complex impact on the pet eye care market, initially disrupting routine veterinary visits while ultimately boosting pet ownership and healthcare spending. Lockdowns increased pet adoptions significantly, expanding the long-term patient base. While non-urgent eye consultations were delayed in early 2020, telemedicine consultations for chronic conditions like dry eye enabled continuity of care. The shift toward remote work allowed owners to more easily administer frequent topical medications, improving treatment adherence. As veterinary practices reopened with enhanced safety protocols, pent-up demand for elective procedures generated strong recovery. Overall, the pandemic accelerated the trend toward viewing pets as essential family members requiring comprehensive medical care, including specialized ophthalmology.

The Topical segment is expected to be the largest during the forecast period

The Topical segment is expected to account for the largest market share during the forecast period, driven by the predominance of easily treatable anterior segment diseases including conjunctivitis, keratoconjunctivitis sicca (dry eye), and corneal ulcers. Eye drops, ointments, and gels are typically the first-line therapy prescribed by veterinarians due to their direct application to affected tissues, rapid onset of action, and minimal systemic side effects. Owner preference for non-invasive treatments that can be administered at home without specialized training further supports this segment's dominance. The availability of generic formulations and over-the-counter lubricants also contributes to volume, while ongoing innovation in preservative-free formulations enhances patient comfort and adherence across all animal types.

The Cats segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Cats segment is predicted to witness the highest growth rate, reflecting increasing feline ownership and rising awareness of breed-specific ocular conditions in cats. Conditions such as feline herpesvirus-associated conjunctivitis, eosinophilic keratitis, and progressive retinal atrophy are driving specialized veterinary attention. Urbanization and indoor confinement of cats have increased the prevalence of certain eye diseases, while advances in diagnostic imaging enable earlier detection. The growing availability of feline-friendly topical formulations and oral medications improves treatment compliance compared to historically difficult-to-dose cats. As more owners recognize that cats, like dogs, can benefit from aggressive eye care management, this segment accelerates faster than the mature canine market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high rates of pet ownership, advanced veterinary infrastructure, and widespread pet health insurance adoption. The United States alone has over 85 million pet-owning households, with ophthalmology referrals routinely covered by comprehensive insurance plans. Presence of leading veterinary pharmaceutical companies and specialized animal eye clinics in the region ensures rapid product availability and specialist access. Strong public awareness of treatable eye diseases, driven by veterinary associations and pet health campaigns, encourages early intervention. The region's willingness to spend on advanced diagnostics and surgical procedures continues to sustain North America's dominant market position throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rapidly rising pet ownership in China, India, and Southeast Asian countries, coupled with growing middle-class disposable incomes. Urbanization and smaller family sizes have increased companion animal adoption, while Western-influenced pet humanization trends drive demand for specialized veterinary services. Emerging veterinary schools and specialty training programs are expanding the pool of ophthalmologists and technicians capable of delivering advanced eye care. Government initiatives to strengthen animal healthcare infrastructure and rising domestic manufacturing of affordable pharmaceutical products further accelerate market growth. As awareness campaigns reach previously underserved rural areas, Asia Pacific emerges as the fastest-growing regional market for pet eye care.

Key players in the market

Some of the key players in Pet Eye Care Market include Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Virbac, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Ceva Sante Animale, Hester Biosciences Limited, Ocu-GLO, I-MED Pharma Inc., Akorn Operating Company LLC, Menicon Co., Ltd., Optixcare, and Nutramax Laboratories Veterinary Sciences Inc.

Key Developments:

In April 2026, Elanco launched several new companion animal products, including the Advantage(TM) Collar, signaling a continued push to diversify its pet health portfolio. This follows a period of heavy R&D investment in "blockbuster" potential products intended for chronic conditions in pets.

In February 2026, Merck Animal Health received the 2025 S&P Global Award for "Best Product: Companion Animal" for NUMELVI(R). The award recognized the company's sustained innovation in the pet sector, marking the 8th consecutive year Merck has been honored for its companion animal portfolio.

In January 2026, Boehringer Ingelheim entered a strategic collaboration with Eko Health Inc. to integrate AI-powered diagnostic tools into veterinary practice. While initially focused on cardiology, the company noted that this AI infrastructure will eventually support broader diagnostic categories, including ophthalmic screening.

Products Covered:

Ophthalmic Drugs
Eye Care Solutions & Cleaners
Nutritional Supplements
Protective Eyewear

Equipments Covered:

Diagnostic Equipment
Surgical Equipment
Ocular Implants & Consumables

Indications Covered:

Conjunctivitis
Dry Eye (Keratoconjunctivitis Sicca)
Corneal Disorders
Glaucoma
Cataract
Retinal & Uveal Disorders
Other Eye Conditions

Route of Administrations Covered:

Topical
Oral
Injectable

Animal Types Covered:

Dogs
Cats
Horses
Other Pets

End Users Covered:

Veterinary Hospitals
Veterinary Clinics
Home Care Settings
Research & Academic Institutes

Distribution Channels Covered:

Veterinary Pharmacies
Retail Pharmacies
Pet Specialty Stores
Online Platforms

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Pet Eye Care Market, By Product

5.1 Ophthalmic Drugs
- 5.1.1 Antibiotics
- 5.1.2 Anti-inflammatory Drugs
- 5.1.3 Lubricants / Artificial Tears
- 5.1.4 Other Therapeutics
5.2 Eye Care Solutions & Cleaners
5.3 Nutritional Supplements
5.4 Protective Eyewear

6 Global Pet Eye Care Market, By Equipment

6.1 Diagnostic Equipment
- 6.1.1 Ophthalmoscopes
- 6.1.2 Tonometry Devices
- 6.1.3 Fundus Cameras
- 6.1.4 Imaging Systems
6.2 Surgical Equipment
6.3 Ocular Implants & Consumables

7 Global Pet Eye Care Market, By Indication

7.1 Conjunctivitis
7.2 Dry Eye (Keratoconjunctivitis Sicca)
7.3 Corneal Disorders
7.4 Glaucoma
7.5 Cataract
7.6 Retinal & Uveal Disorders
7.7 Other Eye Conditions

8 Global Pet Eye Care Market, By Route of Administration

8.1 Topical
8.2 Oral
8.3 Injectable

9 Global Pet Eye Care Market, By Animal Type

9.1 Dogs
9.2 Cats
9.3 Horses
9.4 Other Pets

10 Global Pet Eye Care Market, By End User

10.1 Veterinary Hospitals
10.2 Veterinary Clinics
10.3 Home Care Settings
10.4 Research & Academic Institutes

11 Global Pet Eye Care Market, By Distribution Channel

11.1 Veterinary Pharmacies
11.2 Retail Pharmacies
11.3 Pet Specialty Stores
11.4 Online Platforms

12 Global Pet Eye Care Market, By Geography

12.1 North America
- 12.1.1 United States
- 12.1.2 Canada
- 12.1.3 Mexico
12.2 Europe
- 12.2.1 United Kingdom
- 12.2.2 Germany
- 12.2.3 France
- 12.2.4 Italy
- 12.2.5 Spain
- 12.2.6 Netherlands
- 12.2.7 Belgium
- 12.2.8 Sweden
- 12.2.9 Switzerland
- 12.2.10 Poland
- 12.2.11 Rest of Europe
12.3 Asia Pacific
- 12.3.1 China
- 12.3.2 Japan
- 12.3.3 India
- 12.3.4 South Korea
- 12.3.5 Australia
- 12.3.6 Indonesia
- 12.3.7 Thailand
- 12.3.8 Malaysia
- 12.3.9 Singapore
- 12.3.10 Vietnam
- 12.3.11 Rest of Asia Pacific
12.4 South America
- 12.4.1 Brazil
- 12.4.2 Argentina
- 12.4.3 Colombia
- 12.4.4 Chile
- 12.4.5 Peru
- 12.4.6 Rest of South America
12.5 Rest of the World (RoW)
- 12.5.1 Middle East
  - 12.5.1.1 Saudi Arabia
  - 12.5.1.2 United Arab Emirates
  - 12.5.1.3 Qatar
  - 12.5.1.4 Israel
  - 12.5.1.5 Rest of Middle East
- 12.5.2 Africa
  - 12.5.2.1 South Africa
  - 12.5.2.2 Egypt
  - 12.5.2.3 Morocco
  - 12.5.2.4 Rest of Africa

13 Strategic Market Intelligence

13.1 Industry Value Network and Supply Chain Assessment
13.2 White-Space and Opportunity Mapping
13.3 Product Evolution and Market Life Cycle Analysis
13.4 Channel, Distributor, and Go-to-Market Assessment

14 Industry Developments and Strategic Initiatives

14.1 Mergers and Acquisitions
14.2 Partnerships, Alliances, and Joint Ventures
14.3 New Product Launches and Certifications
14.4 Capacity Expansion and Investments
14.5 Other Strategic Initiatives

15 Company Profiles

15.1 Zoetis Inc.
15.2 Elanco Animal Health Incorporated
15.3 Boehringer Ingelheim International GmbH
15.4 Merck & Co., Inc.
15.5 Virbac
15.6 Dechra Pharmaceuticals PLC
15.7 Vetoquinol S.A.
15.8 Ceva Sante Animale
15.9 Hester Biosciences Limited
15.10 Ocu-GLO
15.11 I-MED Pharma Inc.
15.12 Akorn Operating Company LLC
15.13 Menicon Co., Ltd.
15.14 Optixcare
15.15 Nutramax Laboratories Veterinary Sciences Inc.

簡介目錄圖表

List of Tables

Table 1 Global Pet Eye Care Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Pet Eye Care Market Outlook, By Product (2023-2034) ($MN)
Table 3 Global Pet Eye Care Market Outlook, By Ophthalmic Drugs (2023-2034) ($MN)
Table 4 Global Pet Eye Care Market Outlook, By Antibiotics (2023-2034) ($MN)
Table 5 Global Pet Eye Care Market Outlook, By Anti-inflammatory Drugs (2023-2034) ($MN)
Table 6 Global Pet Eye Care Market Outlook, By Lubricants / Artificial Tears (2023-2034) ($MN)
Table 7 Global Pet Eye Care Market Outlook, By Other Therapeutics (2023-2034) ($MN)
Table 8 Global Pet Eye Care Market Outlook, By Eye Care Solutions & Cleaners (2023-2034) ($MN)
Table 9 Global Pet Eye Care Market Outlook, By Nutritional Supplements (2023-2034) ($MN)
Table 10 Global Pet Eye Care Market Outlook, By Protective Eyewear (2023-2034) ($MN)
Table 11 Global Pet Eye Care Market Outlook, By Equipment (2023-2034) ($MN)
Table 12 Global Pet Eye Care Market Outlook, By Diagnostic Equipment (2023-2034) ($MN)
Table 13 Global Pet Eye Care Market Outlook, By Ophthalmoscopes (2023-2034) ($MN)
Table 14 Global Pet Eye Care Market Outlook, By Tonometry Devices (2023-2034) ($MN)
Table 15 Global Pet Eye Care Market Outlook, By Fundus Cameras (2023-2034) ($MN)
Table 16 Global Pet Eye Care Market Outlook, By Imaging Systems (2023-2034) ($MN)
Table 17 Global Pet Eye Care Market Outlook, By Surgical Equipment (2023-2034) ($MN)
Table 18 Global Pet Eye Care Market Outlook, By Ocular Implants & Consumables (2023-2034) ($MN)
Table 19 Global Pet Eye Care Market Outlook, By Indication (2023-2034) ($MN)
Table 20 Global Pet Eye Care Market Outlook, By Conjunctivitis (2023-2034) ($MN)
Table 21 Global Pet Eye Care Market Outlook, By Dry Eye (Keratoconjunctivitis Sicca) (2023-2034) ($MN)
Table 22 Global Pet Eye Care Market Outlook, By Corneal Disorders (2023-2034) ($MN)
Table 23 Global Pet Eye Care Market Outlook, By Glaucoma (2023-2034) ($MN)
Table 24 Global Pet Eye Care Market Outlook, By Cataract (2023-2034) ($MN)
Table 25 Global Pet Eye Care Market Outlook, By Retinal & Uveal Disorders (2023-2034) ($MN)
Table 26 Global Pet Eye Care Market Outlook, By Other Eye Conditions (2023-2034) ($MN)
Table 27 Global Pet Eye Care Market Outlook, By Route of Administration (2023-2034) ($MN)
Table 28 Global Pet Eye Care Market Outlook, By Topical (2023-2034) ($MN)
Table 29 Global Pet Eye Care Market Outlook, By Oral (2023-2034) ($MN)
Table 30 Global Pet Eye Care Market Outlook, By Injectable (2023-2034) ($MN)
Table 31 Global Pet Eye Care Market Outlook, By Animal Type (2023-2034) ($MN)
Table 32 Global Pet Eye Care Market Outlook, By Dogs (2023-2034) ($MN)
Table 33 Global Pet Eye Care Market Outlook, By Cats (2023-2034) ($MN)
Table 34 Global Pet Eye Care Market Outlook, By Horses (2023-2034) ($MN)
Table 35 Global Pet Eye Care Market Outlook, By Other Pets (2023-2034) ($MN)
Table 36 Global Pet Eye Care Market Outlook, By End User (2023-2034) ($MN)
Table 37 Global Pet Eye Care Market Outlook, By Veterinary Hospitals (2023-2034) ($MN)
Table 38 Global Pet Eye Care Market Outlook, By Veterinary Clinics (2023-2034) ($MN)
Table 39 Global Pet Eye Care Market Outlook, By Home Care Settings (2023-2034) ($MN)
Table 40 Global Pet Eye Care Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)
Table 41 Global Pet Eye Care Market Outlook, By Distribution Channel (2023-2034) ($MN)
Table 42 Global Pet Eye Care Market Outlook, By Veterinary Pharmacies (2023-2034) ($MN)
Table 43 Global Pet Eye Care Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
Table 44 Global Pet Eye Care Market Outlook, By Pet Specialty Stores (2023-2034) ($MN)
Table 45 Global Pet Eye Care Market Outlook, By Online Platforms (2023-2034) ($MN)